AstraZeneca To Invest $3.5 Bln In US To Expand R&D And Manufacturing

(RTTNews) - British drug maker AstraZeneca Plc (AZN.L, AZN) announced Tuesday a $3.5 billion capital investment in the United States, aiming to expand its research and manufacturing footprint by the end of 2026. https://www.nasdaq.com/articles/astrazeneca-invest-35-bln-us-expand-rd-and-manufacturing